{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:45Z","timestamp":1787021265987,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1208\/s12249-018-1124-y","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T14:59:13Z","timestamp":1532444353000},"page":"2990-2999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tablet Formulation of a Polymeric Solid Dispersion Containing Amorphous Alkalinized Telmisartan"],"prefix":"10.1208","volume":"19","author":[{"given":"Jun Soo","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Ram","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Jun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Tae","family":"Goo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yub","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Wook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"issue":"12","key":"1124_CR1","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","volume":"359","author":"Salim Yusuf","year":"2008","unstructured":"Yusuf S, Diener HC, Sacco RL, Cotton D, \u00d4unpuu S, Lawton WA, Palesch Y, Albers GW, Bath P, Bornstein N, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. New Engl J Med 2016;359:1225\u20131237.","journal-title":"New England Journal of Medicine"},{"key":"1124_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/147323000002800401","volume":"28","author":"J Stangier","year":"2000","unstructured":"Stangier J, Su CAPF, Roth W. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J Int Med Res. 2000;28:149\u201367.","journal-title":"J Int Med Res"},{"key":"1124_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejpb.2010.05.010","volume":"76","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Jiang T, Zhang Q, Wang S. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property. Eur J Pharm Biopharm. 2010;76:17\u201323.","journal-title":"Eur J Pharm Biopharm"},{"key":"1124_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jconrel.2008.04.001","volume":"129","author":"PHL Tran","year":"2008","unstructured":"Tran PHL, Tran HTT, Lee BJ. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Control Release. 2008;129:59\u201365.","journal-title":"J Control Release"},{"key":"1124_CR5","unstructured":"Antoncic L, Copar A. U.S. patent application no. 11 2009;718, 838."},{"key":"1124_CR6","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3109\/03639045.2013.841188","volume":"40","author":"L Zhong","year":"2014","unstructured":"Zhong L, Zhu X, Yu B, Su W. Influence of alkalizers on dissolution properties of telmisartan in solid dispersions prepared by cogrinding. Drug Dev Ind Pharm. 2014;40:1660\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"1124_CR7","first-page":"341","volume":"2","author":"SN Kothawade","year":"2010","unstructured":"Kothawade SN, Kadam NR, Aragade PD, Baheti DG. Formulation and characterization of telmisatan solid dispersions. Int J Pharmtech Res. 2010;2:341\u20137.","journal-title":"Int J Pharmtech Res"},{"key":"1124_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijpharm.2012.12.020","volume":"441","author":"J Park","year":"2013","unstructured":"Park J, Cho W, Cha KH, Ahn J, Han K, Hwang SJ. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process. Int J Pharm. 2013;441:50\u20135.","journal-title":"Int J Pharm"},{"key":"1124_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijpharm.2006.02.021","volume":"316","author":"S Siepe","year":"2006","unstructured":"Siepe S, Lueckel B, Kramer A, Ries A, Gurny R. Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int J Pharm. 2006;316:14\u201320.","journal-title":"Int J Pharm"},{"key":"1124_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejpb.2006.07.001","volume":"65","author":"T Riis","year":"2007","unstructured":"Riis T, Bauer-Brandl A, Wagner T, Kranz H. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. Eur J Pharm Biopharm. 2007;65:78\u201384.","journal-title":"Eur J Pharm Biopharm"},{"key":"1124_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ijpharm.2012.11.012","volume":"441","author":"N Marasini","year":"2013","unstructured":"Marasini N, Tran TH, Poudel BK, Cho HJ, Choi YK, Chi SC, et al. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Int J Pharm. 2013;441:424\u201332.","journal-title":"Int J Pharm"},{"key":"1124_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jddst.2017.01.001","volume":"37","author":"JS Choi","year":"2017","unstructured":"Choi JS. Enhanced stability and solubility of pH-dependent drug telmisartan achieved by solid dispersion. J Drug Deliv Sci Technol. 2017;37:194\u2013203.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1124_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40005-017-0310-3","volume":"47","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Fukunishi A, Higashino H, Kataoka M, Wada K. Design of supersaturable formulation of telmisartan with pH modifier: in vitro study on dissolution and precipitation. J Pharm Investig. 2017;47:163\u201371.","journal-title":"J Pharm Investig"},{"key":"1124_CR14","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1002\/jps.22579","volume":"100","author":"DE Alonzo","year":"2011","unstructured":"Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GG, Taylor LS. Dissolution and precipitation behavior of amorphous solid dispersions. J Pharm Sci. 2011;100:3316\u201331.","journal-title":"J Pharm Sci"},{"key":"1124_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.14227\/DT180111P39","volume":"18","author":"AK Mahapatra","year":"2011","unstructured":"Mahapatra AK, Murthy PN, Biswal S, Mahapatra AP, Pradhan SP. Dissolution enhancement and physicochemical characterization of valsartan in solid dispersions with \u03b2-CD, HP \u03b2-CD, and PVP K-30. Dissolut Technol. 2011;18:39\u201345.","journal-title":"Dissolut Technol"},{"key":"1124_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijpharm.2003.07.010","volume":"267","author":"K Yamashita","year":"2003","unstructured":"Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm. 2003;267:79\u201391.","journal-title":"Int J Pharm"},{"key":"1124_CR17","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/jps.22074","volume":"99","author":"F Qian","year":"2010","unstructured":"Qian F, Huang J, Hussain MA. Drug\u2013polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development. J Pharm Sci. 2010;99:2941\u20137.","journal-title":"J Pharm Sci"},{"key":"1124_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijpharm.2013.05.013","volume":"453","author":"S Xu","year":"2013","unstructured":"Xu S, Dai WG. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm. 2013;453:36\u201343.","journal-title":"Int J Pharm"},{"key":"1124_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12272-011-0508-2","volume":"34","author":"HLT Phuong","year":"2011","unstructured":"Phuong HLT, Tran TTD, Lee SA, Nho VH, Chi SC, Lee BJ. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan. Arch Pharm Res. 2011;34:747\u201355.","journal-title":"Arch Pharm Res"},{"key":"1124_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"C Leuner","year":"2000","unstructured":"Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47\u201360.","journal-title":"Eur J Pharm Biopharm"},{"key":"1124_CR21","first-page":"40","volume":"7","author":"S Shah","year":"2012","unstructured":"Shah S, Joshi S, Lin S, Madan PL. Preparation and characterization of spironolactone solid dispersions using hydrophilic carriers. Asian J Pharm Sci. 2012;7:40\u20139.","journal-title":"Asian J Pharm Sci"},{"key":"1124_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ijpharm.2011.09.007","volume":"420","author":"DH Oh","year":"2011","unstructured":"Oh DH, Kang JH, Kim DW, Lee BJ, Kim JO, Yong CS, et al. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 2011;420:412\u20138.","journal-title":"Int J Pharm"},{"key":"1124_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/0973-8398.63983","volume":"4","author":"R Kane","year":"2010","unstructured":"Kane R, Kuchekar B. Preparation, physicochemical characterization, dissolution and formulation studies of telmisartan cyclodextrin inclusion complexes. Asian J Pharm. 2010;4:52.","journal-title":"Asian J Pharm"},{"key":"1124_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1517\/17425250902835506","volume":"5","author":"K Sugano","year":"2009","unstructured":"Sugano K. Introduction to computational oral absorption simulation. Expert Opin Drug Metab Toxicol. 2009;5:259\u201393.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1124_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jps.22760","volume":"101","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, Minamisono T, Yamashita T, Kato T, Kushida I. Supersaturation\u2013nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012;101:214\u201322.","journal-title":"J Pharm Sci"},{"key":"1124_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/9780470517833","volume-title":"Additives and crystallization processes: from fundamentals to applications","author":"K Sangwal","year":"2007","unstructured":"Sangwal K. Additives and crystallization processes: from fundamentals to applications. Chichester: John Wiley & Sons Ltd; 2007."},{"key":"1124_CR27","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/jps.21650","volume":"98","author":"J Brouwers","year":"2009","unstructured":"Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98:2549\u201372.","journal-title":"J Pharm Sci"},{"key":"1124_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12272-010-2231-9","volume":"33","author":"DX Li","year":"2010","unstructured":"Li DX, Han MJ, Balakrishnan P, Yan YD, Oh DH, Joe JH, et al. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Arch Pharm Res. 2010;33:95\u2013101.","journal-title":"Arch Pharm Res"},{"key":"1124_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3109\/1061186X.2010.525652","volume":"18","author":"DB Warren","year":"2010","unstructured":"Warren DB, Benameur H, Porter CJ, Pouton CW. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target. 2010;18:704\u201331.","journal-title":"J Drug Target"},{"issue":"Suppl 1","key":"1124_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/0975-7406.94142","volume":"4","author":"B Patel","year":"2012","unstructured":"Patel B, Parikh RH, Swarnkar D. Enhancement of dissolution of telmisartan through use of solid dispersion technique-surface solid dispersion. J Pharm Bioallied Sci. 2012;4(Suppl 1):64.","journal-title":"J Pharm Bioallied Sci"},{"key":"1124_CR31","first-page":"385","volume":"15","author":"Y Cao","year":"2016","unstructured":"Cao Y, Shi LL, Cao QR, Yang M, Cui JH. In-vitro characterization and oral bioavailability of organic solvent-free solid dispersions containing telmisartan. Iran J Pharm Res. 2016;15:385.","journal-title":"Iran J Pharm Res"},{"key":"1124_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1211\/0022357001774831","volume":"52","author":"MS Nagarsenker","year":"2000","unstructured":"Nagarsenker MS, Meshram RN, Ramprakash G. Solid dispersion of hydroxypropyl \u03b2-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats. J Pharm Pharmacol. 2000;52:949\u201356.","journal-title":"J Pharm Pharmacol"},{"key":"1124_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1358\/mf.2006.28.7.1003549","volume":"28","author":"SGV Kumar","year":"2006","unstructured":"Kumar SGV, Mishra DN. Analgesic, anti-inflammatory, and ulcerogenic studies of meloxicam solid dispersion prepared with polyethylene glycol 6000. Methods Find Exp Clin Pharmacol. 2006;28:419.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"1124_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-5173(01)00891-2","volume":"231","author":"DQ Craig","year":"2002","unstructured":"Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131\u201344.","journal-title":"Int J Pharm"},{"key":"1124_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ejps.2013.05.003","volume":"49","author":"R Dukeck","year":"2013","unstructured":"Dukeck R, Sieger P, Karmwar P. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective. Eur J Pharm Sci. 2013;49:723\u201331.","journal-title":"Eur J Pharm Sci"},{"key":"1124_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejpb.2006.01.016","volume":"63","author":"E Karavas","year":"2006","unstructured":"Karavas E, Ktistis G, Xenakis A, Georgarakis E. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J Pharm Biopharm. 2006;63:103\u201314.","journal-title":"Eur J Pharm Biopharm"},{"key":"1124_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2005.10.002","volume":"110","author":"JY Hong","year":"2006","unstructured":"Hong JY, Kim JK, Song YK, Park JS, Kim CK. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release. 2006;110:332\u20138.","journal-title":"J Control Release"},{"key":"1124_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2007.01.035","volume":"338","author":"MG Herting","year":"2007","unstructured":"Herting MG, Kleinebudde P. Roll compaction\/dry granulation: effect of raw material particle size on granule and tablet properties. Int J Pharm. 2007;338:110\u20138.","journal-title":"Int J Pharm"},{"key":"1124_CR39","first-page":"822","volume":"1","author":"T Kiran","year":"2009","unstructured":"Kiran T, Shastri N, Ramakrishna S, Sadanandam M. Surface solid dispersion of glimepiride for enhancement of dissolution rate. Int J Pharmtech Res. 2009;1:822\u201331.","journal-title":"Int J Pharmtech Res"},{"key":"1124_CR40","first-page":"1","volume":"1","author":"AB Patil","year":"2010","unstructured":"Patil AB, Ramchandra VK, Dhananjay SS, Trushali SK, Bhaskar BG, Vivek SK, et al. Formulation and evaluation of solid dispersion of telmisartan with KOH as alkaliser by hot melt method. J Pharm Biomed Sci. 2010;1:1\u20137.","journal-title":"J Pharm Biomed Sci"},{"key":"1124_CR41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jpba.2008.11.002","volume":"50","author":"M Cirri","year":"2009","unstructured":"Cirri M, Maestrelli F, Mennini N, Mura P. Influence of the preparation method on the physical\u2013chemical properties of ketoprofen\u2013cyclodextrin\u2013phosphatidylcholine ternary systems. J Pharm Biomed Anal. 2009;50:690\u20134.","journal-title":"J Pharm Biomed Anal"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1124-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1124-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1124-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T19:03:04Z","timestamp":1563908584000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1124-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1124-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"20 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}